Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 2
1997 2
1999 2
2001 1
2002 2
2003 8
2004 4
2005 5
2006 6
2007 9
2008 9
2009 10
2010 4
2011 4
2012 7
2013 3
2014 10
2015 12
2016 11
2017 6
2018 8
2019 8
2020 9
2021 9
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. Conroy T, et al. N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923. N Engl J Med. 2011. PMID: 21561347 Free article. Clinical Trial.
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Conroy T, Castan F, Lopez A, Turpin A, Ben Abdelghani M, Wei AC, Mitry E, Biagi JJ, Evesque L, Artru P, Lecomte T, Assenat E, Bauguion L, Ychou M, Bouché O, Monard L, Lambert A, Hammel P; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. JAMA Oncol. 2022 Nov 1;8(11):1571-1578. doi: 10.1001/jamaoncol.2022.3829. JAMA Oncol. 2022. PMID: 36048453 Free PMC article. Clinical Trial.
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, Borbath I, Bouché O, Shannon J, André T, Mineur L, Chibaudel B, Bonnetain F, Louvet C; LAP07 Trial Group. Hammel P, et al. JAMA. 2016 May 3;315(17):1844-53. doi: 10.1001/jama.2016.4324. JAMA. 2016. PMID: 27139057 Clinical Trial.
FIV vector systems.
Sauter SL, Gasmi M. Sauter SL, et al. Among authors: gasmi m. Somat Cell Mol Genet. 2001 Nov;26(1-6):99-129. doi: 10.1023/a:1021078714105. Somat Cell Mol Genet. 2001. PMID: 12465464 Review.
Sphincter of Oddi dysfunction.
Boivineau G, Gonzalez JM, Gasmi M, Vitton V, Barthet M. Boivineau G, et al. Among authors: gasmi m. J Visc Surg. 2022 Mar;159(1S):S16-S21. doi: 10.1016/j.jviscsurg.2022.01.008. Epub 2022 Feb 4. J Visc Surg. 2022. PMID: 35131149
Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B, Lisotti A, Caillol F, Gasmi M, Ah-Soune P, Belle A, Charachon A, Cholet F, Eyraud PY, Grandval P, Gonzalez JM, Habersetzer F, Koch S, Le Rhun M, Mangialavori L, Musquer N, Palazzo M, Poincloux L, Privat J, Sportes A, Stouvenot M, Subtil C, Thomassin L, Vanbiervliet G, Vidal G, Vuitton L, Giovannini M, Barthet M. Napoléon B, et al. Among authors: gasmi m. Gastrointest Endosc. 2023 Sep;98(3):392-399.e1. doi: 10.1016/j.gie.2023.04.003. Epub 2023 Apr 12. Gastrointest Endosc. 2023. PMID: 37059368
Superior vesical fissure.
Ghribi A, Ben Slama A, Gasmi M, Sghairoun N, Hamzaoui M. Ghribi A, et al. Among authors: gasmi m. Tunis Med. 2014 Dec;92(12):766-8. Tunis Med. 2014. PMID: 25879612 No abstract available.
Manufacturing of Viral Gene Therapies.
Ramirez GA, Gasmi M. Ramirez GA, et al. Among authors: gasmi m. Int Ophthalmol Clin. 2021 Jul 1;61(3):91-112. doi: 10.1097/IIO.0000000000000362. Int Ophthalmol Clin. 2021. PMID: 34196319 No abstract available.
Endoscopic ultrasound-guided gastroenterostomy with lumen-apposing metal stents: a retrospective multicentric comparison of wireless and over-the-wire techniques.
Monino L, Perez-Cuadrado-Robles E, Gonzalez JM, Snauwaert C, Alric H, Gasmi M, Ouazzani S, Benosman H, Deprez PH, Rahmi G, Cellier C, Moreels TG, Barthet M. Monino L, et al. Among authors: gasmi m. Endoscopy. 2023 Nov;55(11):991-999. doi: 10.1055/a-2119-7529. Epub 2023 Jun 28. Endoscopy. 2023. PMID: 37380033
143 results